当前位置:首页 - 行情中心 - 山东药玻(600529) - 财务分析

山东药玻

(600529)

  

流通市值:146.66亿  总市值:146.66亿
流通股本:6.64亿   总股本:6.64亿

山东药玻(600529)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至2025年半年度实现净利润3.71亿元,每股收益0.56元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至2025年半年度最新股东权益816454.17万元,未分配利润413418.60万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至2025年半年度最新总资产997546.26万元,负债181092.09万元。

利润表
报告期2025-06-302025-03-312024-12-312024-09-30
营业总收入2,373,844,830.371,242,455,243.55,125,270,640.683,824,950,899.24
营业总成本1,901,614,186.9982,600,179.314,013,019,482.722,966,963,655.72
其他经营收益
营业利润444,092,441.69266,839,417.51,112,760,817.8873,195,745.02
利润总额441,547,642.49266,914,530.671,110,805,053.19872,199,139.73
净利润371,141,622223,629,434.88942,991,305.41720,431,146.66
每股收益
其他综合收益----
综合收益总额371,141,622223,629,434.88942,991,305.41720,431,146.66
资产负债表
报告期2025-06-302025-03-312024-12-312024-09-30
流动资产:
流动资产合计5,906,627,859.566,054,844,132.515,980,458,741.735,945,154,109.56
非流动资产:
非流动资产合计4,068,834,718.964,118,521,689.114,159,550,624.114,033,853,686.34
资产总计9,975,462,578.5210,173,365,821.6210,140,009,365.849,979,007,795.9
流动负债:
流动负债合计1,680,931,466.041,813,628,913.032,000,567,167.162,080,709,181.17
非流动负债:
非流动负债合计129,989,449129,451,043.52131,672,508.13110,700,597.67
负债合计1,810,920,915.041,943,079,956.552,132,239,675.292,191,409,778.84
所有者权益(或股东权益):
归属于母公司股东权益合计8,164,541,663.488,230,285,865.078,007,769,690.557,787,598,017.06
股东权益合计8,164,541,663.488,230,285,865.078,007,769,690.557,787,598,017.06
负债和股东权益合计9,975,462,578.5210,173,365,821.6210,140,009,365.849,979,007,795.9
现金流量表
报告期2025-06-302025-03-312024-12-312024-09-30
经营活动产生的现金流量:
经营活动现金流入小计2,655,036,091.171,328,700,650.065,238,740,917.653,999,117,010.56
经营活动现金流出小计2,355,595,344.521,238,167,440.494,073,690,549.753,186,039,238.82
经营活动产生的现金流量净额299,440,746.6590,533,209.571,165,050,367.9813,077,771.74
投资活动产生的现金流量:
投资活动现金流入小计4,387,693,186.491,598,445,580.56,489,936,751.094,781,146,372.42
投资活动现金流出小计4,573,845,660.911,588,412,908.917,607,785,101.035,695,855,757.55
投资活动产生的现金流量净额-186,152,474.4210,032,671.59-1,117,848,349.94-914,709,385.13
筹资活动产生的现金流量:
筹资活动现金流入小计----
筹资活动现金流出小计180,554,602.56-464,529,879.1265,445,645.2
筹资活动产生的现金流量净额-180,554,602.56--464,529,879.1-265,445,645.2
汇率变动对现金及现金等价物的影响7,833,614.043,842,789.2915,608,495.179,611,409.5
现金及现金等价物净增加额-59,432,716.29104,408,670.45-401,719,365.97-357,465,849.09
期末现金及现金等价物余额825,748,645.42989,590,032.16885,181,361.71929,434,878.59
补充资料:
现金及现金等价物的净增加额-59,432,716.29--401,719,365.97-
最新报告期:2025-09-05
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
中信证券陈竹,韩世通1.281.461.652025-09-05
长江证券李浩,范超1.191.351.512025-09-02
光大证券孙伟风1.211.441.572025-09-01
开源证券余汝意,张绪成1.331.431.562025-08-29
西南证券杜向阳1.101.261.342025-08-28
TOP↑